- Supplier site
- Group of sites (click to zoom)
Scientist.com supplier network (site locations)
Research supplier
Facilipharma
Facilipharma is listed as a new startup research supplier in the Scientist.com network, with 1 site in 1 country.
View Facilipharma on Scientist.com
Email me this page as a PDF
Sign in to Scientist.com to open this supplier in your organization's marketplace.
Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Sites
1
Countries
1
Services
What this research supplier says it provides, as listed in the Scientist.com network.
Type of company: New startup
HEOR
- Systematic Literature Review Summarizes the results of research (that meet pre-defined eligibility criteria for inclusion) and provides a high level of evidence on the outcomes assessed.
Market Access
- Emerging Market Opportunities Analyze risks and opportunities in new markets and ensure patients have timely and continued access to new treatments.
- Formulary & Reimbursement Strategy Develop strategy and narrative to gain formulary access on insurance plans.
- Health Technology Assessment Submission (HTA Submission) Analyze the medical, social, ethical, humanistic, and economic considerations of a drug, medical device, or clinical procedures. Submissions are sent to regulatory agencies with different requirements that govern...
- Life Science Reports Life Science reports
- Market Access Materials Find general strategies and methods used to market a pharmaceutical product or device.
- Pricing Strategy Develop value story tailored to a payer audience that will determine the appropriate price for treatment.
Show all 8 in Market Access
- Value Based Agreements or Outcomes-Based Contracts Collaborate with payer or provider to develop a reimbursement plan outside of the traditional fixed cost-per-unit that ties reimbursement or price to actual health outcomes.
- Value Dossiers Development Summary document that presents clinical, economic, and humanistic value of an intervention and associated disease state with the supporting evidence, formulated from the perspective of a particular stakeholder...
Medical Communications
- Abstracts Request services related to the writing and review of abstracts
- Medical Literature Reviews Systematic searching, appraisal, and synthesis of published scientific literature to generate evidence-based reports on a specific topic, disease, or treatment.
- Medical Publications Make clear and accurate presentations of scientific and technical data.
- Poster Design and Development Design and Develop Posters for Poster Symposiums and conferences to effectively convey science information.
- Publication Writing Create further publication documents. Investigational device exemptions (IDEs) BLAs, MAA, PMA, eCTDs, informed consents, CMC and manufacturing reports, orphan drug designations (ODD), briefing books.
Show all 18 services
Old Category HEOR, RWE, Market Access
- Health Technology Assessment Submission (HTA Submission) (DUPLICATE) Conduct a multidisciplinary process that determines the value of a health technology through different points in its lifecycle.
Regulatory Affairs
- Life Cycle Management Plan and strategy of the data collection and information throughout the different phases of product development (portfolio assessment, pre-clinical trials, clinical trials, pre-authorization, post-authorization, and RWE)
- Regulatory Submission Documents Request services related to the submission and writing of New Drug Applications (NDA), Investigational New Drugs (INDs), and Investigator Brochures (IB) to the FDA and other regulatory bodies.
- Risk Benefit Assessment Determine ratio of treatment risk to the potential benefits.
- Website
- facilipharma.com
Where it operates
Sites by country, with the cities in each.
-
United Kingdom 1 site
Work with Facilipharma on Scientist.com
For prices, more details, or to contact Facilipharma, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.